Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if (a) he and (b) the Minister for Public Health and Prevention will meet the hon. Member for Lancaster and Wyre to discuss further safety issues to prevent avoidable harm from Sodium Valproate in pregnancy.

The Medicines and Healthcare products Regulatory Agency (MHRA) is taking proactive steps to inform the public on the very latest safety issues relating to sodium valproate in pregnancy. The MHRA has, most recently in May 2025, approved updated safety and educational materials to support the implementation of the pregnancy prevention programme and the regulatory measures announced in the November 2023 National Patient Safety Alert, as well as the September 2024 Drug Safety Update. We would welcome the Hon. Member to write to the Department, where we can provide due consideration to any points raised.